Drug could be promising new option against eczema
A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition—eczema.
- Next story COVID-19 has slowed medical innovations, study shows
- Previous story In utero exposure to tiny air pollution particles is linked to asthma in preschoolers
Explore more
- How this one-minute mobile film festival is bringing together filmmakers from across Africa
A pregnant woman trying to make it through the Covid-19 pandemic in... - Army clashes with anti-junta militia in Mandalay, Myanmar’s second-biggest city
Myanmar security forces backed by armored vehicles on Tuesday clashed with a... - Meet the Nun Who Wants You to Remember You Will Die
Suffering and death are facts of life: “Everyone dies, their bodies rot,... - China Censors Chloé Zhao’s Oscar Win
On social media, the director’s fans blurred out her name and turned... - Excess deaths estimated for ESRD patients during COVID-19
(HealthDay)—A total of 8.7 to 12.9 excess deaths were estimated per 1,000... - Carbon dioxide in the air at highest level since measurements began
Despite a massive reduction in commuting and in many commercial activities during... - Loneliness won’t end when the pandemic ends
When the world goes back to normal, Shanan Cale’s life won’t change... - Non-optimal codons enable coronaviruses’ promiscuity
Since March 2020 the Cancer Genomics and BioComputing of Complex Diseases Laboratory... - Study tracks the spread of COVID-19 in Sweden
During the pandemic, the free COVID Symptom Study app has helped researchers... - Too much, too little or just right: Researchers study proper ‘dosing’ of telehealth
More than ever, patients are using telehealth to ask doctors and nurses...